Craig-Hallum analyst Matt Hewitt downgraded Champions Oncology to Hold from Buy with a price target of $6, down from $9.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CSBR: